The big story of April wasn't any particular new deal but the apparent resolution of an old one—the Abbott-Alere merger. Deal volume remained brisk, particularly in the alliance arena. But for those … [Read more...]
NEWS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
May 22, 2017
NEW PRODUCTS
Key Coverage Determinations and Product Developments
April 10, 2017
Although several companies secured favorable diagnostic coverage determinations in March, the big winner was Vermillion, manufacturer of the OVA1 ovarian cancer early detection test—the test covered … [Read more...]
NEWS
Diagnostic Deals: A Roundup of Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions
March 31, 2017
Two-thirds of the way through the month, March has seen a relatively high volume of strategic deals but mostly of the marginal variety, particularly with regard to M&A activity. M&A The … [Read more...]
DEALS
Strategic Alliances Promote Test Access and Development
March 27, 2017
In the early months of 2017, the diagnostic industry has seen several strategic alliances develop. Among the most active companies in February so far is Quest Diagnostics which cut a deal to secure … [Read more...]
DEALS
Hologic Sells Blood Screening Business
March 20, 2017
During a slow month for diagnostic M&A activity, a noteworthy deal was Grifols's acquisition of Hologic's blood screening business. The acquired assets include a San Diego plant, development … [Read more...]
NEWSMAKERS
Veracyte Announces Big Developments
March 7, 2017
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew significantly. Percepta Gets Thumbs Up … [Read more...]
NEWS
Diagnostic Deals: A Roundup of February’s Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions
February 28, 2017
After January's flurry of deals, the M&A front has been relatively quiet so far this month. But relatively low volume of M&A deals has been more than offset by surges in strategic alliances … [Read more...]
DEALS
LabCorp Announces Plan to Acquire PAML
February 27, 2017
Late last week, LabCorp and the owners of Pathology Associates Medical Laboratories (known as PAML) announced that LabCorp would acquire ownership of PAML and PAML's interests in several joint … [Read more...]
INDUSTRY BUZZ
Deal of the Month: $25 Billion Acquisition of St. Jude Med Cements Abbott as Leader in Cardiovascular Device Market
January 30, 2017
In a month with an unusually heavy volume of diagnostic deal making, the headline story was Abbott Laboratories' $25 billion purchase of fellow device-making giant St. Jude Medical, which finally … [Read more...]
NEWS
Diagnostic Deals: A Roundup of January’s Mergers, Acquisitions, Alliances, Licenses and Other Major Transactions
January 23, 2017
January 2017 has already seen an unusually high volume of diagnostic deal making. Here is a quick overview of the key deals and what they portend. M&A While Abbott Laboratories made the … [Read more...]
